Last reviewed · How we verify

Enhanced Recovery After Surgery — Competitive Intelligence Brief

Enhanced Recovery After Surgery (Enhanced Recovery After Surgery) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Surgery/Perioperative Medicine.

marketed Surgery/Perioperative Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Enhanced Recovery After Surgery (Enhanced Recovery After Surgery) — Aga Khan University. Enhanced Recovery After Surgery (ERAS) is a perioperative care protocol that optimizes patient preparation, anesthesia, and postoperative management to reduce surgical stress and accelerate recovery.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Enhanced Recovery After Surgery TARGET Enhanced Recovery After Surgery Aga Khan University marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Enhanced Recovery After Surgery — Competitive Intelligence Brief. https://druglandscape.com/ci/enhanced-recovery-after-surgery. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: